1 Luseogliflozin Market Overview 1.1 Product Overview and Scope of Luseogliflozin 1.2 Luseogliflozin Segment by Type 1.2.1 Global Luseogliflozin Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 2.5mg 1.2.3 5mg 1.3 Luseogliflozin Segment by Application 1.3.1 Global Luseogliflozin Sales Comparison by Application: (2022-2028) 1.3.2 Diabetes 1.3.3 Heart Disease 1.3.4 Periodontitis 1.4 Global Luseogliflozin Market Size Estimates and Forecasts 1.4.1 Global Luseogliflozin Revenue 2017-2028 1.4.2 Global Luseogliflozin Sales 2017-2028 1.4.3 Luseogliflozin Market Size by Region: 2017 Versus 2021 Versus 2028 2 Luseogliflozin Market Competition by Manufacturers 2.1 Global Luseogliflozin Sales Market Share by Manufacturers (2017-2022) 2.2 Global Luseogliflozin Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Luseogliflozin Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Luseogliflozin Manufacturing Sites, Area Served, Product Type 2.5 Luseogliflozin Market Competitive Situation and Trends 2.5.1 Luseogliflozin Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Luseogliflozin Players Market Share by Revenue 2.5.3 Global Luseogliflozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Luseogliflozin Retrospective Market Scenario by Region 3.1 Global Luseogliflozin Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Luseogliflozin Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Luseogliflozin Market Facts & Figures by Country 3.3.1 North America Luseogliflozin Sales by Country 3.3.2 North America Luseogliflozin Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Luseogliflozin Market Facts & Figures by Country 3.4.1 Europe Luseogliflozin Sales by Country 3.4.2 Europe Luseogliflozin Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Luseogliflozin Market Facts & Figures by Region 3.5.1 Asia Pacific Luseogliflozin Sales by Region 3.5.2 Asia Pacific Luseogliflozin Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Luseogliflozin Market Facts & Figures by Country 3.6.1 Latin America Luseogliflozin Sales by Country 3.6.2 Latin America Luseogliflozin Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Luseogliflozin Market Facts & Figures by Country 3.7.1 Middle East and Africa Luseogliflozin Sales by Country 3.7.2 Middle East and Africa Luseogliflozin Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Luseogliflozin Historic Market Analysis by Type 4.1 Global Luseogliflozin Sales Market Share by Type (2017-2022) 4.2 Global Luseogliflozin Revenue Market Share by Type (2017-2022) 4.3 Global Luseogliflozin Price by Type (2017-2022) 5 Global Luseogliflozin Historic Market Analysis by Application 5.1 Global Luseogliflozin Sales Market Share by Application (2017-2022) 5.2 Global Luseogliflozin Revenue Market Share by Application (2017-2022) 5.3 Global Luseogliflozin Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Taisho Toyama 6.1.1 Taisho Toyama Corporation Information 6.1.2 Taisho Toyama Description and Business Overview 6.1.3 Taisho Toyama Luseogliflozin Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Taisho Toyama Luseogliflozin Product Portfolio 6.1.5 Taisho Toyama Recent Developments/Updates 6.2 Novartis 6.2.1 Novartis Corporation Information 6.2.2 Novartis Description and Business Overview 6.2.3 Novartis Luseogliflozin Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Novartis Luseogliflozin Product Portfolio 6.2.5 Novartis Recent Developments/Updates 6.3 Mitsubishi Tanabe Pharma 6.3.1 Mitsubishi Tanabe Pharma Corporation Information 6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview 6.3.3 Mitsubishi Tanabe Pharma Luseogliflozin Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Mitsubishi Tanabe Pharma Luseogliflozin Product Portfolio 6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates 6.4 CR Double-Crane 6.4.1 CR Double-Crane Corporation Information 6.4.2 CR Double-Crane Description and Business Overview 6.4.3 CR Double-Crane Luseogliflozin Sales, Revenue and Gross Margin (2017-2022) 6.4.4 CR Double-Crane Luseogliflozin Product Portfolio 6.4.5 CR Double-Crane Recent Developments/Updates 7 Luseogliflozin Manufacturing Cost Analysis 7.1 Luseogliflozin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Luseogliflozin 7.4 Luseogliflozin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Luseogliflozin Distributors List 8.3 Luseogliflozin Customers 9 Luseogliflozin Market Dynamics 9.1 Luseogliflozin Industry Trends 9.2 Luseogliflozin Market Drivers 9.3 Luseogliflozin Market Challenges 9.4 Luseogliflozin Market Restraints 10 Global Market Forecast 10.1 Luseogliflozin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Luseogliflozin by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Luseogliflozin by Type (2023-2028) 10.2 Luseogliflozin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Luseogliflozin by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Luseogliflozin by Application (2023-2028) 10.3 Luseogliflozin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Luseogliflozin by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Luseogliflozin by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Luseogliflozin Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Luseogliflozin Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Luseogliflozin Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Luseogliflozin Market Competitive Situation by Manufacturers in 2021 Table 5. Global Luseogliflozin Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Luseogliflozin Sales Market Share by Manufacturers (2017-2022) Table 7. Global Luseogliflozin Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Luseogliflozin Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Luseogliflozin Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Luseogliflozin Manufacturing Sites and Area Served Table 11. Manufacturers Luseogliflozin Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Luseogliflozin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Luseogliflozin as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Luseogliflozin Sales by Region (2017-2022) & (K Units) Table 16. Global Luseogliflozin Sales Market Share by Region (2017-2022) Table 17. Global Luseogliflozin Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Luseogliflozin Revenue Market Share by Region (2017-2022) Table 19. North America Luseogliflozin Sales by Country (2017-2022) & (K Units) Table 20. North America Luseogliflozin Sales Market Share by Country (2017-2022) Table 21. North America Luseogliflozin Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Luseogliflozin Revenue Market Share by Country (2017-2022) Table 23. Europe Luseogliflozin Sales by Country (2017-2022) & (K Units) Table 24. Europe Luseogliflozin Sales Market Share by Country (2017-2022) Table 25. Europe Luseogliflozin Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Luseogliflozin Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Luseogliflozin Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Luseogliflozin Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Luseogliflozin Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Luseogliflozin Revenue Market Share by Region (2017-2022) Table 31. Latin America Luseogliflozin Sales by Country (2017-2022) & (K Units) Table 32. Latin America Luseogliflozin Sales Market Share by Country (2017-2022) Table 33. Latin America Luseogliflozin Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Luseogliflozin Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Luseogliflozin Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Luseogliflozin Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Luseogliflozin Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Luseogliflozin Revenue Market Share by Country (2017-2022) Table 39. Global Luseogliflozin Sales by Type (2017-2022) & (K Units) Table 40. Global Luseogliflozin Sales Market Share by Type (2017-2022) Table 41. Global Luseogliflozin Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Luseogliflozin Revenue Share by Type (2017-2022) Table 43. Global Luseogliflozin Price by Type (2017-2022) & (US$/Unit) Table 44. Global Luseogliflozin Sales (K Units) by Application (2017-2022) Table 45. Global Luseogliflozin Sales Market Share by Application (2017-2022) Table 46. Global Luseogliflozin Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Luseogliflozin Revenue Share by Application (2017-2022) Table 48. Global Luseogliflozin Price by Application (2017-2022) & (US$/Unit) Table 49. Taisho Toyama Corporation Information Table 50. Taisho Toyama Description and Business Overview Table 51. Taisho Toyama Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. Taisho Toyama Luseogliflozin Product Table 53. Taisho Toyama Recent Developments/Updates Table 54. Novartis Corporation Information Table 55. Novartis Description and Business Overview Table 56. Novartis Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. Novartis Luseogliflozin Product Table 58. Novartis Recent Developments/Updates Table 59. Mitsubishi Tanabe Pharma Corporation Information Table 60. Mitsubishi Tanabe Pharma Description and Business Overview Table 61. Mitsubishi Tanabe Pharma Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Mitsubishi Tanabe Pharma Luseogliflozin Product Table 63. Mitsubishi Tanabe Pharma Recent Developments/Updates Table 64. CR Double-Crane Corporation Information Table 65. CR Double-Crane Description and Business Overview Table 66. CR Double-Crane Luseogliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. CR Double-Crane Luseogliflozin Product Table 68. CR Double-Crane Recent Developments/Updates Table 69. Production Base and Market Concentration Rate of Raw Material Table 70. Key Suppliers of Raw Materials Table 71. Luseogliflozin Distributors List Table 72. Luseogliflozin Customers List Table 73. Luseogliflozin Market Trends Table 74. Luseogliflozin Market Drivers Table 75. Luseogliflozin Market Challenges Table 76. Luseogliflozin Market Restraints Table 77. Global Luseogliflozin Sales Forecast by Type (2023-2028) & (K Units) Table 78. Global Luseogliflozin Sales Market Share Forecast by Type (2023-2028) Table 79. Global Luseogliflozin Revenue Forecast by Type (2023-2028) & (US$ Million) Table 80. Global Luseogliflozin Revenue Market Share Forecast by Type (2023-2028) Table 81. Global Luseogliflozin Sales Forecast by Application (2023-2028) & (K Units) Table 82. Global Luseogliflozin Sales Market Share Forecast by Application (2023-2028) Table 83. Global Luseogliflozin Revenue Forecast by Application (2023-2028) & (US$ Million) Table 84. Global Luseogliflozin Revenue Market Share Forecast by Application (2023-2028) Table 85. Global Luseogliflozin Sales Forecast by Region (2023-2028) & (K Units) Table 86. Global Luseogliflozin Sales Market Share Forecast by Region (2023-2028) Table 87. Global Luseogliflozin Revenue Forecast by Region (2023-2028) & (US$ Million) Table 88. Global Luseogliflozin Revenue Market Share Forecast by Region (2023-2028) Table 89. Research Programs/Design for This Report Table 90. Key Data Information from Secondary Sources Table 91. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Luseogliflozin Figure 2. Global Luseogliflozin Market Share by Type in 2021 & 2028 Figure 3. 2.5mg Product Picture Figure 4. 5mg Product Picture Figure 5. Global Luseogliflozin Market Share by Application in 2021 & 2028 Figure 6. Diabetes Figure 7. Heart Disease Figure 8. Periodontitis Figure 9. Global Luseogliflozin Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Luseogliflozin Market Size (2017-2028) & (US$ Million) Figure 11. Global Luseogliflozin Sales (2017-2028) & (K Units) Figure 12. Luseogliflozin Sales Share by Manufacturers in 2021 Figure 13. Global Luseogliflozin Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Luseogliflozin Players: Market Share by Revenue in 2021 Figure 15. Luseogliflozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Luseogliflozin Sales Market Share by Region (2017-2022) Figure 17. Global Luseogliflozin Sales Market Share by Region in 2021 Figure 18. Global Luseogliflozin Revenue Market Share by Region (2017-2022) Figure 19. Global Luseogliflozin Revenue Market Share by Region in 2021 Figure 20. United States Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. China Taiwan Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Mexico Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Brazil Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Argentina Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Turkey Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Saudi Arabia Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. UAE Luseogliflozin Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Sales Market Share of Luseogliflozin by Type (2017-2022) Figure 43. Manufacturing Cost Structure of Luseogliflozin Figure 44. Manufacturing Process Analysis of Luseogliflozin Figure 45. Luseogliflozin Industrial Chain Analysis Figure 46. Channels of Distribution Figure 47. Distributors Profiles Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Taisho Toyama Novartis Mitsubishi Tanabe Pharma CR Double-Crane